259.
Roth F, Wuthrich H. The clinical importance of hyperkalaemia following suxamethonium administration. Br J Anaesth 1969;41:311– 316.
260.
Silberman H. Renal failure and the surgeon. Surg Gynecol Obstet 1977;144:775–784.
261.
Bullock ML, Umen AJ, Finkelstein M, et al. The assessment of risk factors in 462 patients with acute renal failure. Am J Kidney Dis 1985;5:97–103.
262.
Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243–248.
263.
Meyer RD. Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides. Am J Med 1986;80:119–125.
264.
Shusterman N, Strom BL, Murray TG, et al. Risk factors and outcome of hospital-acquired acute renal failure. Clinical epidemiologic study. Am J Med 1987;83:65–71.
265.
Lameire NH. Contrast-induced nephropathy—prevention and risk reduction. Nephrol Dial Transplant 2006;21:i11–i23.
266.
Bush HL Jr, Huse JB, Johnson WC, et al. Prevention of renal insufficiency after abdominal aortic aneurysm resection by optimal volume loading. Arch Surg 1981;116:1517–1524.
267.
Cebul RD, Beck JR. Biochemical profiles. Applications in ambulatory screening and preadmission testing of adults. Ann Intern Med 1987;106:403–413.
268.
Batchelder BM, Cooperman LH. Effects of anesthetics on splanchnic circulation and metabolism. Surg Clin North Am 1975;55:787– 794.
269.
Maze M, Bass NM. Anesthesia and the hepatobilliary system.New York: Churchill Livingstone, 2000.
270.
Child C, Turcotte JG. Surgery and portal hypertension. In: Child C, ed. The liver and portal hypertension. Philadelphia, PA: WB Saunders, 1964:1–85.
271.
Mansour A, Watson W, Sahyani V, et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997;122:730–736.
272.
Telem DA, Schiano T, Goldstone R, et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol 2010;8:451–458.
273.
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470.
274.
Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864–871.
275.
Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 2007;4:266– 276.
276.